Chembio Stock Performance


USD 0.64  0.01  1.54%   

The firm shows a Beta (market volatility) of 0.6545, which signifies possible diversification benefits within a given portfolio. Let's try to break down what Chembio's beta means in this case. As returns on the market increase, Chembio Diagnostics returns are expected to increase less than the market. However, during the bear market, the loss on holding Chembio Diagnostics will be expected to be smaller as well. Even though it is essential to pay attention to Chembio Diagnostics historical returns, it is always good to be careful when utilizing equity current trending patterns. Our philosophy in foreseeing any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Chembio Diagnostics exposes twenty-seven different technical indicators, which can help you to evaluate its performance. Chembio Diagnostics has an expected return of -0.15%. Please be advised to confirm Chembio Diagnostics coefficient of variation, potential upside, rate of daily change, as well as the relationship between the sortino ratio and skewness to decide if Chembio Diagnostics performance from the past will be repeated at some point in the near future.
Chembio Performance
0 of 100
Over the last 90 days Chembio Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's primary indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders. ...more

Structure and Payout Changes

Last Split Factor
Last Split Date

Chembio Price Channel

Quick Ratio2.63
Fifty Two Week Low0.4200
Fifty Two Week High7.3400

Chembio Diagnostics Relative Risk vs. Return Landscape

If you would invest  79.00  in Chembio Diagnostics on April 3, 2022 and sell it today you would lose (15.00)  from holding Chembio Diagnostics or give up 18.99% of portfolio value over 90 days. Chembio Diagnostics is currently does not generate positive expected returns and assumes 6.201% risk (volatility on return distribution) over the 90 days horizon. In different words, 53% of stocks are less volatile than Chembio, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
 Daily Expected Return (%) 
      Risk (%) 
Given the investment horizon of 90 days Chembio Diagnostics is expected to generate 4.31 times more return on investment than the market. However, the company is 4.31 times more volatile than its market benchmark. It trades about -0.02 of its potential returns per unit of risk. The DOW is currently generating roughly -0.12 per unit of risk.

Chembio Diagnostics Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Chembio Diagnostics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Chembio Diagnostics, and traders can use it to determine the average amount a Chembio Diagnostics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0243

Good Returns
Average Returns
Small Returns
Negative ReturnsCEMI
Estimated Market Risk
  actual daily
 53 %
of total potential
Expected Return
  actual daily
 0 %
of total potential
Risk-Adjusted Return
  actual daily
 0 %
of total potential
Based on monthly moving average Chembio Diagnostics is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Chembio Diagnostics by adding it to a well-diversified portfolio.

About Chembio Diagnostics Performance

To evaluate Chembio Diagnostics Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Chembio Diagnostics generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Chembio Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Chembio Diagnostics stock market performance in a much more refined way. At Macroaxis, we take it even further. The Macroaxis performance score is an integer between 0 and 100 that represents Chembio's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Effect of Exchange Rate Changes on Cash-240.4 K-246.8 K
Return on Investment(62.44) (64.08) 
Return on Average Assets(0.51) (0.53) 
Return on Average Equity(1.12) (1.16) 
Return on Invested Capital(0.59) (0.61) 
Return on Sales(0.65) (0.67) 
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care diagnostic tests that are used to detect or diagnose diseases. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Hauppauge, New York. Chembio Diagnostics operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 337 people.

Things to note about Chembio Diagnostics

Checking the ongoing alerts about Chembio Diagnostics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Chembio Diagnostics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Chembio Diagnostics Alerts

Equity Alerts and Improvement Suggestions

Chembio Diagnostics generated a negative expected return over the last 90 days
Chembio Diagnostics has high historical volatility and very poor performance
Chembio Diagnostics has some characteristics of a very speculative penny stock
Chembio Diagnostics has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 47.82 M. Net Loss for the year was (33.9 M) with profit before overhead, payroll, taxes, and interest of 12.83 M.
Chembio Diagnostics currently holds about 28.77 M in cash with (30.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Latest headline from Rapid Test Kits Market 2022 Study An Emerging Hint of Opportunity Cellex, Abbott, Roche Indian Defence News - Indian Defence News
Continue to Trending Equities. Note that the Chembio Diagnostics information on this page should be used as a complementary analysis to other Chembio Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for Chembio Stock analysis

When running Chembio Diagnostics price analysis, check to measure Chembio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chembio Diagnostics is operating at the current time. Most of Chembio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Chembio Diagnostics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chembio Diagnostics' price. Additionally, you may evaluate how the addition of Chembio Diagnostics to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Fundamental Analysis
View fundamental data based on most recent published financial statements
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Bond Directory
Find actively traded corporate debentures issued by US companies
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Is Chembio Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chembio Diagnostics. If investors know Chembio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chembio Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
19.2 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Chembio Diagnostics is measured differently than its book value, which is the value of Chembio that is recorded on the company's balance sheet. Investors also form their own opinion of Chembio Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Chembio Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chembio Diagnostics' market value can be influenced by many factors that don't directly affect Chembio Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chembio Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine Chembio Diagnostics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chembio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.